Tudor Investment Corp’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,829
Closed -$175K 1329
2017
Q2
$175K Sell
11,829
-10,432
-47% -$174K 0.01% 913
2017
Q1
$355K Sell
22,261
-12,639
-36% -$182K 0.01% 898
2016
Q4
$440K Buy
34,900
+24,700
+242% +$460K 0.01% 787
2016
Q3
$286K Buy
+10,200
New +$342K 0.01% 1052
2016
Q1
Sell
-16,499
Closed -$565K 2060
2015
Q4
$565K Sell
16,499
-7,501
-31% -$234K 0.02% 780
2015
Q3
$690K Buy
+24,000
New +$1.03M 0.02% 572
2015
Q2
Sell
-16,750
Closed -$579K 1748
2015
Q1
$579K Buy
+16,750
New +$456K 0.02% 659

Other funds holding DPLO

Tudor Investment Corp's DPLO Position: Q3 2017 in Review

Tudor Investment Corp sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 11,829 shares — an estimated $175K sold.

Tudor Investment Corp first reported a position in DPLO in Q1 2015 and held it in 7 quarters. The position peaked at $690K in Q3 2015. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

  • Tudor Investment Corp reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 11,829 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $175K.
  • Tudor Investment Corp first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 7 quarters.
  • Tudor Investment Corp's DIPLOMAT PHARMACY, INC. position peaked at $690K in Q3 2015.
  • 165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.